Trevi Therapeutics, Inc. TRVI Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s total current liabilities?
- Trevi Therapeutics, Inc. (TRVI) reported total current liabilities of $7.12M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Trevi Therapeutics, Inc.'s total current liabilities increased by 3.6% year-over-year, from $6.87M to $7.12M.
- What is the long-term trend for Trevi Therapeutics, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Trevi Therapeutics, Inc.'s total current liabilities has grown at a 11.9% compound annual growth rate (CAGR), from $5.56M to $9.75M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.